Drugs / OMS302-PE
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00721695 Comparator | May 2008 → Feb 2009 | cataract | Omeros Corporation | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OMS302-PE | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00721695 ↗ |